Navigation Links
Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
Date:8/30/2012

CORTLANDT MANOR, N.Y., Aug. 30, 2012 /PRNewswire/ -- Polymedco Cancer Diagnostic Products, LLC ("Polymedco CDP") is pleased to announce that a distribution agreement was signed with MedPrimex, LLC ("MedPrimex").  The agreement provides distribution rights, for the Mexican market, to MedPrimex for Polymedco CDP fecal immunochemical test (FIT) product line for screening for colorectal cancer (CRC).  Colorectal cancer is among the leading causes of cancer death worldwide, but nearly half of people who die failed to get screened.

Early detection and treatment dramatically increase chances of survival. Screening is the most realistic approach to reducing new cases by finding non-cancerous colorectal polyps and removing them before they become cancerous. 

The OC automated FIT and manual OC Light® tests are quick and easy screening methods that measure human hemoglobin in the patient's stool.  The tests can be performed at home with little disruption to the patient's daily routine – requiring only one sample collection and no changes to diet or medication. The higher specificity of FIT means that there are less false positive results.

"Our goal is to introduce the benefits of getting an annual screening using a fecal immunochemical test (FIT) to people of Mexico," said Drew Cervasio, President of Polymedco. "Innovations in screening have significantly improved the detection of breast, prostate and cervical cancers so it is time to pay attention to the advances that can drive more patients to find colorectal cancer earlier."

"Through these screening tests, we are better able to accurately identify at-risk patients and send more of the right patients for further evaluation and colonoscopy," said Ana Maria Pedroza, CEO of MedPrimex. "We are proud to be a part of an effort that will ensure citizens of our country will have access to the best options for their healthcare needs."

About Polymedco Cancer Diagnostic Products, LLC

Polymedco Cancer Diagnostic Products, LLC is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and devices that are specialized in cancer. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC -Auto® product line. Since 1980, Polymedco has evolved into a highly skilled and successful marketing, sales, and manufacturing organization.

Combined with an experienced team of field representatives and strong technical service personnel, Polymedco Cancer Diagnostic Products provides a high level of customer, technical and reimbursement support. To reach Polymedco Inc. via the worldwide web, log on to www.polymedco.com.

About MedPrimex, LLC

MedPrimex is a trusted Mexican company specialized in providing medical equipment, early detection systems, and disease prevention to preserve the health of the Mexican population. MedPrimex has strong ties with lead companies to deliver innovative health system solutions and advance medical technology. MedPrimex goal is preserving the health and quality of life of people.

MedPrimex has unparalleled service, expertise, product, and service offerings — delivering solutions that are innovative and practical. MedPrimex focuses on what matters most - improving people's lives. MedPrimex strives to work for the success of their customers by providing exceptional value and superior service to best satisfy their needs.

To reach MedPrimex via the worldwide web, log on to www.medprimex.com.


'/>"/>
SOURCE Polymedco Cancer Diagnostic Products, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
2. Back to School Ideas: Vaccines for Kids Could Hurt Rather Than Help Fight Disease
3. Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world
4. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
5. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
6. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
7. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
8. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
9. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
10. Breast Cancer Diagnostic and Drug Technologies: Global Markets
11. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Feb. 11, 2016  Ampio Pharmaceuticals, Inc. (NYSE MKT: ... entered into a Controlled Equity Offering SM Sales ... Michael Macaluso , Chairman and CEO, stated "During ... are not currently raising money and that we have ... 2017 and still complete all of our current objectives ...
(Date:2/11/2016)... Germany , February 11, 2016 ... up 6.8% to EUR 1,377.2m  Adjusted EBITDA climbs to ... 18.0% to EUR 3.41  Proposed dividend of EUR 0.85 ... sale of glass tubing business and refinancing successfully completed  ... to 5% on organic basis  Adjusted EBITDA expected ...
(Date:2/10/2016)... REDWOOD CITY, Calif., Feb. 10, 2016   Genomic Health, Inc. ... progress for the quarter and year ended December 31, 2015. ... in the fourth quarter of 2015, compared with $69.1 million in ... a constant currency basis, revenue increased 9 percent compared with the ... --> U.S. revenue was $63.9 million in the fourth ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... The Commission for ... the Board of Commissioners. Individuals interested in volunteer board service are encouraged to ... clinical practice settings and across allied health to contribute to its mission and ...
(Date:2/11/2016)... ... February 11, 2016 , ... Greenfield Insurance Group in Orange ... assist the people of their local community. The agency pledges to select a ... Their hope is to bring awareness to important local causes with fundraising and ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... ongoing community involvement program, introduces a new charity campaign to raise funds for ... now being accepted at https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is ...
(Date:2/11/2016)... ... , ... Be Well Medical Group (Be Well) is pleased to ... 108 South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a ... convenience of their homes, offices or at the practices’ local office. It is also ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling for ... health and wellness best practices in the past couple of decades, and food ... American Heart Month, which acts as an exceptional opportunity to revise food labels ...
Breaking Medicine News(10 mins):